These BRG1-KO-induced changes included a morphological shift from epithelial to elongated ‘fibroblast-like’ cells with anoikis-resistant growth capabilities and major epigenome- and transcriptome-wide reprograming that activated EMT and other cancer-related pathways. This evidence concerns the gene SMARCA4 and cancer.